Quadrature Capital LTD Edwards Lifesciences Corp Transaction History

Quadrature Capital LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $4.94 Million - $6.66 Million	71,305 New	71,305 $4.94 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $12.9 Million - $16.5 Million	188,262 Added 452.02%	229,911 $17.2 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.31 Million - $1.71 Million	15,963 Added 62.15%	41,649 $3.45 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $3.85 Million - $5.71 Million	-44,543 Reduced 63.43%	25,686 $2.45 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $3.38 Million - $4.52 Million	58,704 Added 509.36%	70,229 $4.85 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $4.2 Million - $6.49 Million	-80,165 Reduced 87.43%	11,525 $2.18 Million
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $6.46 Million - $7.4 Million	90,090 Added 5630.63%	91,690 $7.13 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $1.06 Million - $1.22 Million	-19,008 Reduced 92.24%	1,600 $0
Q2 2018 Aug 10, 2018	BUY	$42.45 - $51.3 $798,272 - $964,696	18,805 Added 1042.98%	20,608 $0
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $2.9 Million - $3.69 Million	-77,849 Reduced 97.74%	1,803 $0
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $2.89 Million - $3.09 Million	79,652	79,652 $0

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Quadrature Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Quadrature Capital LTD with notifications on news.